ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9522
0.05%
Brent Oil
83.745
0.25%
Bitcoin
57,294.73
-1.62%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) Noticias

POLB

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:POLB
FechaHoraFuenteTítuloSímboloCompañía
01/05/202410:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202401:00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202410:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202401:02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202401:01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202401:00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202401:00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202411:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202402:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202401:00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202407:42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202410:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202401:00RNS Regulatory NewsPoolbeg Pharma PLC Board Role Change and Launch of EIPLSE:POLBPoolbeg Pharma Plc
12/02/202413:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202401:00RNS Regulatory NewsPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRSLSE:POLBPoolbeg Pharma Plc
17/01/202407:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202401:00UK RegulatoryPoolbeg Pharma PLC Further data shows POLB001 potential in cancer CRSLSE:POLBPoolbeg Pharma Plc
20/12/202314:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202301:00UK RegulatoryPoolbeg Pharma PLC RSV AI Drug Candidate Analysis UpdateLSE:POLBPoolbeg Pharma Plc
11/12/202301:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Data Presented at ASHLSE:POLBPoolbeg Pharma Plc
30/11/202301:00UK RegulatoryPoolbeg Pharma PLC Directorate ChangeLSE:POLBPoolbeg Pharma Plc
21/11/202308:39Alliance NewsAlliance NewsTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherLSE:POLBPoolbeg Pharma Plc
21/11/202301:00RNS Non-RegulatoryPoolbeg Pharma PLC Immunomodulator II patent granted in JapanLSE:POLBPoolbeg Pharma Plc
16/11/202301:00RNS Non-RegulatoryPoolbeg Pharma PLC POLB 001 LPS Trial Data to be Presented at IUISLSE:POLBPoolbeg Pharma Plc
09/11/202310:57Alliance NewsAlliance NewsIN BRIEF: Poolbeg Pharma appoints former Amryt executives to teamLSE:POLBPoolbeg Pharma Plc
09/11/202301:00UK RegulatoryPoolbeg Pharma PLC Former Amryt Pharma Leadership Team join PoolbegLSE:POLBPoolbeg Pharma Plc
03/11/202302:05UK RegulatoryPoolbeg Pharma PLC POLB001 Data to be Presented at ASH Annual MeetingLSE:POLBPoolbeg Pharma Plc
01/11/202302:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Oncology Programme Update MeetingLSE:POLBPoolbeg Pharma Plc
26/10/202301:00RNS Non-RegulatoryPoolbeg Pharma PLC SAB Endorses Influenza Drug TargetsLSE:POLBPoolbeg Pharma Plc
17/10/202304:49Alliance NewsAlliance NewsPoolbeg Pharma shares up on metabolic drug collaboration agreementLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
USI
USTECH100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados